• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[一名72岁多发性骨髓瘤患者的异常皮肤改变]

[Unusual skin alterations in a 72-year-old patient with multiple myeloma].

作者信息

Hart C, Wurm S, Hafner C, Andreesen R, Grube M

机构信息

Abteilung für Hämatologie und Internistische Onkologie, Klinik für Innere Medizin I, Universitätsklinikum Regensburg.

出版信息

Internist (Berl). 2012 Apr;53(4):467-73. doi: 10.1007/s00108-011-2996-z.

DOI:10.1007/s00108-011-2996-z
PMID:22274304
Abstract

We report on a 72-year-old female patient with multiple myeloma who presented with alopecia and eye-catching alterations of the skin and the nails. A biopsy of the skin could confirm the diagnosis of immunoglobulin light chain (AL) amyloidosis, which was also suspected of having affected other organs. After six cycles of a cytoreductive therapy with bortezomib and dexamethasone a very good partial response of the multiple myeloma was seen and an improvement in the skin and nail alterations could be achieved.

摘要

我们报告了一名72岁的多发性骨髓瘤女性患者,该患者出现脱发以及皮肤和指甲的显著改变。皮肤活检确诊为免疫球蛋白轻链(AL)淀粉样变性,怀疑其他器官也受到影响。在接受了六个周期的硼替佐米与地塞米松的减瘤治疗后,多发性骨髓瘤出现了非常好的部分缓解,皮肤和指甲的改变也有所改善。

相似文献

1
[Unusual skin alterations in a 72-year-old patient with multiple myeloma].[一名72岁多发性骨髓瘤患者的异常皮肤改变]
Internist (Berl). 2012 Apr;53(4):467-73. doi: 10.1007/s00108-011-2996-z.
2
A rare cause of severe hepatomegaly with an improving outcome.严重肝肿大的一种罕见病因,预后改善。
BMJ Case Rep. 2014 Apr 3;2014:bcr2013203360. doi: 10.1136/bcr-2013-203360.
3
[Outcomes of AL-amyloidosis treatment with bortezomib, dexamethasone and cyclophosphamide or doxorubicin-containing regimens].[硼替佐米、地塞米松和环磷酰胺或含阿霉素方案治疗AL淀粉样变性的结果]
Vnitr Lek. 2012 Dec;58(12):896-903.
4
[IgM-lambda multiple myeloma presenting with systemic amyloidosis].[以系统性淀粉样变性为表现的IgM-λ型多发性骨髓瘤]
Rinsho Ketsueki. 2009 Dec;50(12):1711-4.
5
[Case report; a case of acute kidney injury due to intravenous zoledronic acid hydrate, improved with bortezomib plus dexamethazone therapy in a patient with multiple myeloma].[病例报告;1例静脉注射唑来膦酸水合物所致急性肾损伤,在1例多发性骨髓瘤患者中采用硼替佐米联合地塞米松治疗后病情改善]
Nihon Naika Gakkai Zasshi. 2011 Jan 10;100(1):179-81. doi: 10.2169/naika.100.179.
6
Combined use of bortezomib, cyclophosphamide, and dexamethasone induces favorable hematological and organ responses in Japanese patients with amyloid light-chain amyloidosis: a single-institution retrospective study.硼替佐米、环磷酰胺和地塞米松联合使用对日本轻链型淀粉样变患者诱导出良好的血液学和器官反应:一项单中心回顾性研究
Int J Hematol. 2015 Feb;101(2):133-9. doi: 10.1007/s12185-014-1705-9. Epub 2014 Nov 28.
7
Rapid complete remission in multiple myeloma with bortezomib/thalidomide/dexamethasone combination therapy following development of tumor lysis syndrome.在肿瘤溶解综合征发生后,采用硼替佐米/沙利度胺/地塞米松联合疗法使多发性骨髓瘤迅速完全缓解。
Cancer Chemother Pharmacol. 2008 Jun;62(1):181-2. doi: 10.1007/s00280-007-0574-9. Epub 2007 Aug 31.
8
Bortezomib subcutaneous injection in combination regimens for myeloma or systemic light-chain amyloidosis: a retrospective chart review of response rates and toxicity in newly diagnosed patients.硼替佐米皮下注射联合方案治疗多发性骨髓瘤或系统性轻链淀粉样变性:新诊断患者的反应率和毒性的回顾性图表分析。
Clin Ther. 2013 Oct;35(10):1614-20. doi: 10.1016/j.clinthera.2013.08.015. Epub 2013 Sep 26.
9
[Very good partial response and long time to progression by short-term bortezomib plus dexamethasone therapy for a patient with relapsed and refractory multiple myeloma-a case report].[硼替佐米联合地塞米松短期治疗复发性难治性多发性骨髓瘤患者获非常好的部分缓解且疾病进展时间长——病例报告]
Gan To Kagaku Ryoho. 2009 Aug;36(8):1387-9.
10
Successful treatment of immunoglobulin D myeloma by bortezomib and dexamethasone therapy.硼替佐米与地塞米松联合治疗成功治愈免疫球蛋白D型骨髓瘤。
Intern Med. 2011;50(21):2653-7. doi: 10.2169/internalmedicine.50.5977. Epub 2011 Nov 1.

本文引用的文献

1
Consensus recommendations for standard investigative workup: report of the International Myeloma Workshop Consensus Panel 3.共识建议的标准调查研究:国际骨髓瘤工作组共识小组 3 的报告。
Blood. 2011 May 5;117(18):4701-5. doi: 10.1182/blood-2010-10-299529. Epub 2011 Feb 3.
2
Immunoglobulin light chain amyloidosis: 2011 update on diagnosis, risk-stratification, and management.免疫球蛋白轻链淀粉样变性:诊断、风险分层和治疗的 2011 年更新。
Am J Hematol. 2011 Feb;86(2):180-6. doi: 10.1002/ajh.21934.
3
Systemic light-chain amyloidosis: advances in diagnosis, prognosis, and therapy.
系统性轻链淀粉样变性:诊断、预后和治疗的进展。
Hematology Am Soc Hematol Educ Program. 2010;2010:287-94. doi: 10.1182/asheducation-2010.1.287.
4
Efficacy of the combination of bortezomib and dexamethasone in systemic AL amyloidosis.硼替佐米联合地塞米松治疗系统性淀粉样变的疗效。
Ann Hematol. 2011 Feb;90(2):201-6. doi: 10.1007/s00277-010-1062-6. Epub 2010 Sep 7.
5
Cutaneous amyloidoses and systemic amyloidoses with cutaneous involvement.皮肤淀粉样变和伴有皮肤累及的系统性淀粉样变。
Eur J Dermatol. 2010 Mar-Apr;20(2):152-60. doi: 10.1684/ejd.2010.0842. Epub 2010 Jan 14.
6
[Hereditary and non-hereditary cutaneous amyloidoses].[遗传性和非遗传性皮肤淀粉样变性]
Pathologe. 2009 May;30(3):197-204. doi: 10.1007/s00292-009-1130-7.
7
Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma.多发性骨髓瘤的诊断、分期、风险分层及疗效评估标准。
Leukemia. 2009 Jan;23(1):3-9. doi: 10.1038/leu.2008.291. Epub 2008 Oct 30.
8
Familial myeloma.家族性骨髓瘤
N Engl J Med. 2008 Oct 16;359(16):1734-5; author reply 1735. doi: 10.1056/NEJMc081677.
9
An overview of high-dose melphalan and stem cell transplantation in the treatment of AL amyloidosis.高剂量美法仑与干细胞移植治疗AL淀粉样变性概述
Amyloid. 2007 Dec;14(4):261-9. doi: 10.1080/13506120701613984.
10
Amyloidosis and the lung.淀粉样变性与肺
Chron Respir Dis. 2006;3(4):203-14. doi: 10.1177/1479972306070066.